Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

DEFEROXAMINE MESYLATE FOR INJECTION

PFIZER CANADA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DEFEROXAMINE MESYLATE FOR INJECTION in Canada?

Yes. DEFEROXAMINE MESYLATE FOR INJECTION 2G has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is DEFEROXAMINE MESYLATE FOR INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will DEFEROXAMINE MESYLATE FOR INJECTION be available again?

The manufacturer's estimated resolution date is November 23, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusActive Shortage
Same-ingredient products on file2 products
Expected resolution~11 days remaining (estimate)
Affected strength2G
Report last updated2026-11-05
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

DESFERAL

MITEM PHARMA

500MG · DIN 01981242

Different strengthSame dosage formSame routeNo current shortage

DEFEROXAMINE MESYLATE FOR INJECTION

PFIZER CANADA ULC

500MG · DIN 02241600

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2026-11-23

~11 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02247022

Strength

2G

Dosage Form

POWDER FOR SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR

Active Ingredient

DEFEROXAMINE MESYLATE

Tier

Unrated

Last Updated

2026-11-05

Reason for Shortage

Disruption of the manufacture of the drug.

Past Reports for This Drug

DEFEROXAMINE MESYLATE FOR INJECTION has 2 shortage/discontinuation reports on file — this is one of them.